Compounds having the formula Ia or Ib wherein R.sup.1, R.sup.2, R.sup.3
and R.sup.4 are as defined herein are Hepatitis C virus NS5b polymerase
inhibitors. Also disclosed are compositions and methods for treating an
HCV infection and inhibiting HCV replication. ##STR00001##